555 related articles for article (PubMed ID: 18979289)
21. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
[TBL] [Abstract][Full Text] [Related]
22. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
[TBL] [Abstract][Full Text] [Related]
23. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Mamede M; Higashi T; Kitaichi M; Ishizu K; Ishimori T; Nakamoto Y; Yanagihara K; Li M; Tanaka F; Wada H; Manabe T; Saga T
Neoplasia; 2005 Apr; 7(4):369-79. PubMed ID: 15967114
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
27. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
[TBL] [Abstract][Full Text] [Related]
28. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
[TBL] [Abstract][Full Text] [Related]
29. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
30. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
[TBL] [Abstract][Full Text] [Related]
31. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
[TBL] [Abstract][Full Text] [Related]
32. Biological correlates of FDG uptake in non-small cell lung cancer.
de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
34. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
Tohma T; Okazumi S; Makino H; Cho A; Mochiduki R; Shuto K; Kudo H; Matsubara K; Gunji H; Ochiai T
Hepatogastroenterology; 2005; 52(62):486-90. PubMed ID: 15816463
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
36. In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Mertens K; Mees G; Lambert B; Van de Wiele C; Goethals I
Cancer Biother Radiopharm; 2012 Apr; 27(3):183-8. PubMed ID: 22372557
[TBL] [Abstract][Full Text] [Related]
37. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
[TBL] [Abstract][Full Text] [Related]
38. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
[TBL] [Abstract][Full Text] [Related]
39. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Izuishi K; Yamamoto Y; Mori H; Kameyama R; Fujihara S; Masaki T; Suzuki Y
Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
